Your account is not claimed yet. You can sign up with ORCID to claim your account.

Reza Ahangari Cohan

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 19

Top Venues

Journal of translational medicine

International journal of nanomedicine

PloS one

Microbial cell factories

Pasteur Institute of Iran

Pasteur Institute of Iran (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pasteur Institute of Iran Apr 15o 2012

Iran

Faculty :: Nanobiotechnology

Education History

Pasteur Institute of Iran Sep 23o 2006 - Oct 26o 2011

Iran

PHD :: Nanobiotechnology

Publications

Elnaz Afshari, Reza Ahangari Cohan, Fattah Sotoodehnejadnematalahi, Seyed Fazlollah Mousavi
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A. Journal of translational medicine 21 (1) (2023)
Elnaz Afshari, Reza Ahangari Cohan, Fattah Sotoodehnejadnematalahi, Seyed Fazlollah Mousavi
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A. Journal of translational medicine 21 (1) (2023)
Elnaz Afshari, Reza Ahangari Cohan, Fattah Sotoodehnejadnematalahi, Seyed Fazlollah Mousavi
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A. Journal of translational medicine 21 (1) (2023)
Mahmoud Ganji, Shohreh Bakhshi, Alireza Shoari, Reza Ahangari Cohan
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer. Journal of translational medicine 21 (1) (2023)
Mahmoud Ganji, Shohreh Bakhshi, Alireza Shoari, Reza Ahangari Cohan
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer. Journal of translational medicine 21 (1) (2023)
Elnaz Afshari, Reza Ahangari Cohan, Fattah Sotoodehnejadnematalahi, Seyed Fazlollah Mousavi
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A. Journal of translational medicine 21 (1) (2023)
Mahmoud Ganji, Shohreh Bakhshi, Alireza Shoari, Reza Ahangari Cohan
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer. Journal of translational medicine 21 (1) (2023)
Shima Gholami, Ladan Mafakher, Fatemeh Fotouhi, Bijan Bambai, Reza Ahangari Cohan, Parvaneh Mehrbod, Hadiseh Shokouhi, Behrokh Farahmand
Computational peptide engineering approach for selection of the new C05 antibody-driven peptide with potency to blocking influenza a virus attachment; from in silico to in vivo . Journal of biomolecular structure & dynamics (2023)
Mahmoud Ganji, Shohreh Bakhshi, Alireza Shoari, Reza Ahangari Cohan
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer. Journal of translational medicine 21 (1) (2023)
Arezoo Beig Parikhani, Kowsar Bagherzadeh, Rada Dehghan, Alireza Biglari, Mohammad Ali Shokrgozar, Farhad Riazi Rad, Sirous Zeinali, Yeganeh Talebkhan, Soheila Ajdary, Reza Ahangari Cohan, Mahdi Behdani
Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach. PloS one 17 (2) (2022)
Seyed Shahaboddin Mousavi Motlagh, Mohammad Seyedhamzeh, Reza Ahangari Cohan, Mehdi Shafiee Ardestani, Behrouz Vaziri, Kayhan Azadmanesh, Sahar Saberi, Vahideh Masoumi
Novel G-CSF conjugated anionic globular dendrimer: Preparation and biological activity assessment. Pharmacology research & perspectives 9 (4) (2022)
Fatemeh Ghafouri, Reza Ahangari Cohan, Hilda Samimi, Ali Hosseini Rad S M, Mahmood Naderi, Farshid Noorbakhsh, Vahid Haghpanah
Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study. JMIR bioinformatics and biotechnology 3 (1) (2022)
Fatemeh Sadat Shariati, Malihe Keramati, Reza Ahangari Cohan
Indirect optimization of staphylokinase expression level in dicistronic auto-inducible system. AMB Express 12 (1) (2022)
Farnaz Khodabakhsh, Mahsa Bourbour, Mohammad Tavakkoli Yaraki, Saina Bazzazan, Haleh Bakhshandeh, Reza Ahangari Cohan, Yen Nee Tan
pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy. Molecules (Basel, Switzerland) 27 (17) (2022)
Fatemeh Sadat Shariati, Dariush Norouzian, Vahideh Valizadeh, Reza Ahangari Cohan, Malihe Keramati
Rapid screening of high expressing Escherichia coli colonies using a novel dicistronic-autoinducible system. Microbial cell factories 20 (1) (2021)
Farnaz Khodabakhsh, Morteza Salimian, Ardavan Mehdizadeh, Mohammad Sadeq Khosravy, Alireza Vafabakhsh, Elmira Karami, Reza Ahangari Cohan
New Proline, Alanine, Serine Repeat Sequence for Pharmacokinetic Enhancement of Anti-VEGF Single-Domain Antibody. The Journal of pharmacology and experimental therapeutics 375 (1) (2020)
Navid Gholami, Reza Ahangari Cohan, Alireza Razavi, Razieh Bigdeli, Aziz Dashbolaghi, Vahid Asgary
Cytotoxic and apoptotic properties of a novel nano-toxin formulation based on biologically synthesized silver nanoparticle loaded with recombinant truncated pseudomonas exotoxin A. Journal of cellular physiology 235 (4) (2019)
Azam Akbari, Azim Akbarzadeh, Morteza Rafiee Tehrani, Reza Ahangari Cohan, Mohsen Chiani, Mohammad Reza Mehrabi
Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells. Advanced pharmaceutical bulletin 10 (1) (2019)
Somayeh Sadeghi, Haleh Bakhshandeh, Reza Ahangari Cohan, Afshin Peirovi, Parastoo Ehsani, Dariush Norouzian
Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37. International journal of nanomedicine 14 (2019)

Reza Ahangari Cohan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Reza Ahangari Cohan